Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Reata Pharmaceuticals: Good News from the FDA Regarding Omaveloxolone for Friedreich’s Ataxia

May 19, 2021 0

Reata Pharmaceuticals Good News Reata Pharmaceuticals (RETA) announced it received a communication from the Division of …

An Important Agreement Between Bristol-Myers Squibb and Agenus

May 18, 2021 0

Bristol-Myers Squibb and Agenus Agreement for AGEN1777 Bristol-Myers Squibb (BMY) and Agenus (

More Vaccines from GlaxoSmithKline: One with Sanofi and Another with CureVac

May 17, 2021 0

Sanofi and GlaxoSmithKline COVID-19 Vaccine Sanofi (SNY) and GlaxoSmithKline (GSK

AstraZeneca and Amgen Product Tezepelumab Seems to Overcome the Resistance of Severe Asthma to Current Treatments

May 14, 2021 0

AstraZeneca and Amgen Announced Results for Tezepelumab for Severe Asthma Tezepelumab Reduced Exacerbations by 77% in …

Compugen: First Quarter Financial Results, Accomplishments and Future Plans

May 13, 2021 0

Compugen Updated Trial Data Updated data from COM701 Phase 1 combination and monotherapy studies to be …

Cassava Sciences Awarded NIH Grant. See Also: Intellia Therapeutics Presentations at the 24th ASGCT Meeting

May 12, 2021 0

Cassava Sciences Awarded NIH Research Grant for Simufilam Cassava Sciences (SAVA) announced that it has been …

Sutro Biopharma: First Quarter Financial Results, Business Highlights and More

May 10, 2021 0

Sutro Biopharma Inc Sutro Biopharma (STRO) is a clinical-stage drug discovery, development and manufacturing company. Its …

ADC Therapeutics: Moving from a Development-Stage Firm to a Revenue-Generating Firm

May 7, 2021 0

ADC Therapeutics First Quarter Financial Results and Business Updates ADC Therapeutics SA (ADCT) is a commercial-stage biotechnology …

Editas Medicine: Business Highlights and Financial Results Reported

May 5, 2021 0

Editas Medicine Reporting Editas Medicine (EDIT) reported business highlights and financial results for the first quarter …

Vir Biotechnology

May 4, 2021 0

Prohost Portfolio PLUS #5 Vir Biotechnology Vir Biotechnology (VIR) combines cutting-edge technologies with immunologic insights to …

Gilead Sciences Conference Call Information. See Also: Compugen Announcements

April 29, 2021 0

Gilead Sciences First-Quarter 2021 Financial Results Conference Call Info Gilead Sciences (GILD) management will host a …

AstraZeneca: Tagrisso Recommended for Marketing Authorization in the EU for Early Stage EGFRm NSCLC

April 27, 2021 0

AstraZeneca: Tagrisso for Adult Patients with Early-Stage EGFRm NSCLC... AstraZeneca (AZN): Tagrisso (osimertinib) has been recommended …

Sanofi and AstraZeneca: Nirsevimab Protects Healthy Pre-Term and Term Infants from Respiratory Syncytial Virus

April 27, 2021 0

Sanofi and AstraZeneca MELODY Trial Results for Nirsevimab In March 2017, Sanofi (SNY) and AstraZeneca (

Vertex and CRISPR Therapeutics: The EMA Granted PRIME Designation to CTX001. Read Also: Cassava Sciences Encouraging News

April 26, 2021 0

Vertex and CRISPR Granted PRIME Designation from the EMA for CTX001 Vertex Pharmaceuticals (VRTX) and CRISPR Therapeutics …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Reata Pharmaceuticals: Good News from the FDA Regarding Omaveloxolone for Friedreich’s Ataxia

An Important Agreement Between Bristol-Myers Squibb and Agenus

More Vaccines from GlaxoSmithKline: One with Sanofi and Another with CureVac

AstraZeneca and Amgen Product Tezepelumab Seems to Overcome the Resistance of Severe Asthma to Current Treatments

Compugen: First Quarter Financial Results, Accomplishments and Future Plans

Cassava Sciences Awarded NIH Grant. See Also: Intellia Therapeutics Presentations at the 24th ASGCT Meeting

Sutro Biopharma: First Quarter Financial Results, Business Highlights and More

ADC Therapeutics: Moving from a Development-Stage Firm to a Revenue-Generating Firm

Editas Medicine: Business Highlights and Financial Results Reported

Vir Biotechnology

Gilead Sciences Conference Call Information. See Also: Compugen Announcements

AstraZeneca: Tagrisso Recommended for Marketing Authorization in the EU for Early Stage EGFRm NSCLC

Sanofi and AstraZeneca: Nirsevimab Protects Healthy Pre-Term and Term Infants from Respiratory Syncytial Virus

Vertex and CRISPR Therapeutics: The EMA Granted PRIME Designation to CTX001. Read Also: Cassava Sciences Encouraging News

Celldex Therapeutics See Also: More of Your Questions Answered

Gilead and Eisai Submitted an Application to Japan’s PMDA for Approval of Filgotinib for UC

Bristol-Myers Squibb: CHMP of the EMA Recommended Additional Approval of Onureg® as Maintenance Therapy for AML

Humanigen Inc Product Lenzilumab Combination with CAR T in DLBCL Protects from Severe Cytokine Syndrome

Cassava Sciences Guidance for Simufilam. See Also: Its First Quarter 2021 Financial Results

Vir Biotechnology and GlaxoSmithKline: The European Medicines Agency Started a Review of VIR-7831 for COVID-19